Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression (Q42462940)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 2010
edit
Language Label Description Also known as
English
Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression
scientific article published on May 2010

    Statements

    Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression (English)
    Alexander C Langheinrich
    389-397

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit